Profiles

Keywords
Last Name
Institution

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.

Wasserman RL, Melamed IR, Stein MR, Jolles S, Norton M, Moy JN. Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency. J Clin Immunol. 2017 Apr; 37(3):301-310.

View in: PubMed

collapse authors with profiles